Saudi Arabia’s June oil exports rise 123% to over $16 billion…. they misfired!

DUBAI — The value of Saudi Arabia’s oil exports in June increased 123% to 61.5 billion riyals ($16.4 billion) from a year earlier while non-oil exports rose by around 41%, official data showed on Tuesday.  Overall exports increased by nearly 92% in June compared to a year earlier when international trade was curbed by lockdowns and travel disruptions related to the coronavirus crisis, said the General Authority for Statistics. Saudi Arabia, the world’s biggest oil exporter, was hit hard last year as oil prices plummeted and measures to contain the COVID-19 pandemic hurt its non-oil economy. But the country’s gross domestic product in the second quarter grew for the first time since the coronavirus crisis, on the back of the easing of restrictions and rebounding oil prices. China remained Saudi Arabia’s main trading partner in June, with exports there amounting to nearly 20% of total exports. Imports from Turkey continued to be low, after an informal blockade by Saudi Arabia. In June they fell to 5.7 million riyals from 21.8 in May, and from 712.4 million riyals in June last year. Nick Note: Like many people the Saudi’s made a strategic mistake. They thought the pandemic was over. Sorry no cookie. They like many people have not calculated in the coming death plunge in the global economy from the coming shut downs due to the covid19 delta and other mutations……

 

Conditioned to failure…. Masses buy the dips

“Buy the dips” means purchasing an asset after it has dropped in price. The belief here is that the new lower price represents a bargain as the “dip” is only a short-term blip and the asset, with time, is likely to bounce back and increase in value.

  • Buying the dips refers to going long an asset or security after its price has experienced a short-term decline, in repeated fashion.
  • Buying the dips can be profitable in long-term uptrends, but unprofitable or tougher during secular downtrends.
  • Dip buying can lower one’s average cost of owning a position, but the risk and reward of dip-buying should be constantly evaluated.

“Buy the dips” is a common phrase investors and traders hear after an asset has declined in price in the short-term. After an asset’s price drops from a higher level, some traders and investors view this as an advantageous time to buy or add to an existing position. The concept of buying dips is based on the theory of price waves. When an investor buys an asset after a drop, they are buying at a lower price, hoping to profit if the market rebounds. Buying the dips has several contexts and different odds of working out profitably, depending on the situation. Some traders say they are “buying the dips” if an asset drops within an otherwise long-term uptrend. They hope the uptrend will resume after the drop. Nick Note: In a market where the rally is about to come to an abrupt end. Buy the dips at the present time will guarantee a wipe out. Sure they will get a few bingo’s BUT this rally days are numbered. Five things will kill this party.

  1. The Delta covid mutation will soon suck shut the economy. Travel, leisure and restaurants are dead man walking.
  2. The FED has over stimulated creating the biggest stock market bubble ever
  3. To much money chasing to few goods and services has sparked off embedded inflation.
  4. The FED will have no choice but to throw the stock market under the bus and stop stimulating. taking its foot off the gas.
  5. Even the taper will not be enough and they will slam on the breaks and significantly raise interest rates

It will be horrible trillions will be lost in a matter of days. This coming stock market crash will be among the biggest……. Till then keep you powder dry. You will not have to wait much longer!!!!

Equities gain, U.S. dollar falls; Fed seen less eager to taper

NEW YORK (Reuters) – Global equity markets rose while the U.S. dollar dipped on Monday as investors grew less concerned that the Federal Reserve would soon begin changing its accommodative monetary stance. Market sentiment was buoyed after the U.S. Food and Drug Administration granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine. New cases, driven by the highly infectious Delta variant, have surged in parts of the United States with lower vaccination levels.  The dollar index slid. Last week it hit a nine-month high on bets that the Fed would start shifting away from its accommodative monetary policy, but that view began to change on Friday when Dallas Fed President Robert Kaplan said he might reconsider his hawkish stance if the virus harms the economy.Now, investors are less confident Fed Chair Jerome Powell’s speech at Jackson Hole this week will indicate a timeline for winding down the Fed’s bond-buying program.

“There was a fear that they were going to announce tapering in Jackson Hole and start in September. But it now looks that will be in 2022,” said Thomas Hayes, managing member at Great Hill Capital.

The MSCI world equity index, which tracks shares in 50 countries, rose 1.09%. Last week it had its biggest weekly fall since June. Europe’s STOXX 600 closed higher at 0.66%. (Graphic: USD, https://fingfx.thomsonreuters.com/gfx/mkt/nmovaxwwdpa/USD.png) The U.S. FDA, which had given the two-dose Pfizer/BioNTech vaccine emergency-use authorization in December, went a step further based on updated data and fully approved it for people age 16 and older. The Pentagon then said it was preparing to make the vaccine mandatory for U.S. military personnel. U.S. health officials now expect more vaccine mandates from state and local governments, as well as private employers. On Wall Street, the Dow Jones Industrial Average rose 0.61%, to 35,335.71, the S&P 500 gained 0.85%, to 4,479.53 and the Nasdaq Composite added 1.55%, to 14,942.65. Overnight in Asia, MSCI’s broadest index of Asia-Pacific shares outside Japan closed 1.46% higher, while Japan’s Nikkei rose 1.78%. “It’s a whole combination of factors, the big one being the FDA approval of the vaccine. A lot of people are taking it as good news and then the Fed may not be as keen on tapering as suspected,” said Michael Ashley Schulman, chief investment officer at Running Point Capital. Nick Note: The Fed needs to desperately take its foot off the gas and STOP over stimuilating the economy. Inflation is now imbedded and the masses now fear the inflationary rise they are seing in prices. AS long as the FED is mindlessly adding 150 billion to the economy a month the rally will continue.  At some point inflation will overwhelm the FED and they will be forced to taper.  This will happen as the next wave of covid19 shutdowns suck shut the economy. When the market gets a sniff that the FED is taping the breaks the stock market will crash. So we wait…..

Wall St ends higher, Nasdaq notches record closing high on full vaccine approval

NEW YORK, Aug 23 (Reuters) – Wall Street rallied on Monday, and the Nasdaq reached an all-time closing high as sentiment was boosted by full FDA approval of a COVID-19 vaccine and market participants looked ahead to the Jackson Hole Symposium expected to convene later this week. All three major U.S. stock indexes ended the session sharply higher, with surging crude prices, driven by expected demand growth, putting energy shares out front. “This has been the script all along,” said Peter Cardillo, chief market economist at Spartan Capital Securities in New York. “We make new highs, pull back, and then we’re off to the races again.” “That tells me the fundamentals are in place,” Cardillo added. “There’s worries out there, but it’s hard to keep this market down.” The U.S. Food and Drug Administration (FDA) granted full approval to the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE in a move that could accelerate inoculations in the United States. “Full approval means that there’s most likely going to be more mandates, more companies will mandate that you have to get the vaccine in order to get back to the office,” Cardillo said. “I don’t think this will get all the doubters vaccinated but this news today will probably drive (the vaccinated rate) closer to 75%.” Pfizer and U.S.-listed shares of BioNTech advanced, as did rival Moderna Inc. Spiking COVID-19 infections caused by the highly contagious Delta variant have fueled concerns over a protracted recovery from the global health crisis. Data released on Monday painted a mixed portrait of an economy inching back to normal in the wake of the most abrupt contraction in history. Sales of pre-owned homes unexpectedly increased in July, according to the National Association of Realtors, while a report from IHS Markit showed business activity accelerating this month. The “Goldilocks” portrait of an economic recovery headed in the right direction, but not robust enough to warrant a change in the Federal Reserve’s dovish monetary policy, helped feed investor risk appetite.

Market participants look to the Jackson Hole Symposium, due to convene in Wyoming later this week. Fed Chairman Jerome Powell’s comments will be closely parsed for clues regarding the central bank’s policy-tightening timeline.

Unofficially, the Dow Jones Industrial Average rose 215.63 points, or 0.61%, to 35,335.71, the S&P 500 gained 37.84 points, or 0.85%, to 4,479.51 and the Nasdaq Composite added 227.99 points, or 1.55%, to 14,942.65.

Equities gain, U.S. dollar falls as tapering worries recede

NEW YORK (Reuters) – Global equity markets rose while the U.S. dollar dipped on Monday as investor concerns that the Federal Reserve would soon begin changing its accommodative monetary stance faded. Market sentiment was also buoyed after the U.S. Food and Drug Administration granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, making it the first to secure such official validation. New cases, driven by the highly infectious Delta variant, have surged in parts of the United States with lower vaccination levels.  The dollar index slid on Monday after hitting a nine-month high last week, as investors firmed up bets the Fed will start scaling back pandemic-era stimulus policies ahead of Europe and Japan. But Robert Kaplan, the hawkish president of the Dallas Fed, dented those expectations on Friday when he said he might reconsider the need for an early start to tapering if the virus harms the economy. His comments also doused anticipation that Fed Chair Jerome Powell’s speech at Jackson Hole this week would indicate a timeline for when the central bank would begin ending its bond-buying program. Nick Note: Last week we did not buy into the bear trap. I expect still further market highs… Keep your powder high…. Soon we will cut them a new asshole….

Pfizer jab gets FDA’s full approval

The Food and Drug Administration on Monday announced that it had approved Pfizer and BioNTech’s Covid-19 vaccine, opening the door to more widespread vaccine mandates as schools and universities begin their academic years. The approval comes eight months after the FDA issued Pfizer its first emergency-use authorization for a Covid-19 vaccine on Dec. 11. Since then, more than 204 million doses of the vaccine have been administered in the U.S. alone. On Monday, the FDA’s acting commissioner, Dr. Janet Woodcock, said the approval should boost public confidence in the Pfizer vaccine.

“As the first FDA-approved Covid-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” Woodcock said in a statement.

The agency approved the vaccine in people aged 16 and older. Emergency-use authorization remains in place for those aged 12 to 15. A third dose for immunocompromised individuals is also still authorized, but not yet approved. “I am hopeful this approval will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives and achieve herd immunity,” Pfizer’s CEO, Albert Bourla, said in a statement after the approval was announced. Pfizer shares were up 3.9% Monday morning, while BioNTech’s American depositary receipt was up 9.9%. Moderna (MRNA) shares also climbed 5.5%. Emergency-use authorization is short of the full approval that most vaccines and therapeutics must receive before they can be administered to patients. The FDA and Pfizer have been working toward full approval for months. Neither of the other two Covid-19 vaccines to be authorized in the U.S., from Moderna and Johnson & Johnson (JNJ), has received full approval. Approval of the Pfizer vaccine won’t change much for the hundred million people in the U.S. who have already received it. It could, however, ease the way for businesses and institutions seeking to require vaccination as a condition of returning to in-person work or school.  Speaking on CNN’s State of the Union on Sunday, Surgeon General Dr. Vivek Murthy said full approval could allow for more vaccine mandates. “For businesses and universities that have been thinking about putting vaccine requirements in place in order to create safer spaces for people to work and learn, I think that this move from the FDA, when it comes, will actually help them to move forward with those kinds of plans,” Murthy said. While some vaccine mandates have already been put in place, others have waited on full FDA approval. The Department of Defense, the world’s largest employer, has said it plans to require Covid-19 vaccines for members of the military once the FDA approval is in place. Though there have been legal challenges to vaccine mandates, they have been met with little success in the courts. The Supreme Court in mid-August declined to intercede in a challenge brought by students at Indiana University. The long-term outlook for the pandemic is making a long-lasting and robust market for Covid-19 vaccine boosters look increasingly likely, a bullish sign for the current leading Covid-19 vaccine makers.

Booster COVID-19 shots should be delayed -Says WHO director-general US CDC says get the booster shot!

BUDAPEST (Reuters) – WHO Director-General Tedros Adhanom Ghebreyesus said on Monday that COVID-19 booster shots should be delayed as priority should be given to raising vaccination rates in countries where only 1% or 2% of the population has been inoculated. If vaccination rates are not raised globally, stronger variants of the coronavirus could develop and vaccines intended as booster shots should be donated to countries where people have not received their first or second doses, he said during avisit to Budapest. “In addition, there is a debate about whether booster shots are effective at all,” Ghebreyesus told a news conference with Hungarian Foreign Minister Peter Szijjarto. Those whose immune system is compromised should get a booster shot, though they represent only small percentage of the population, he added. The WHO said last week current data does not indicate that COVID-19 booster shots are needed and that the most vulnerable people worldwide should be fully vaccinated before high-income countries deploy a top-up. The Unites States announced last week it plans to make COVID-19 vaccine booster shots widely available starting on Sept. 20 as infections rise from the coronavirus Delta variant.  Hungary has already started widely distributing booster shots. Nick Note: This WHO prick is a menace to mankind. You might recalled he delayed in declaring the China Plague allowing a lost opportunity to control it early on. The fact is after 6 months your vaccine is 80% gone. Tell him to go fuck himself and get your life saving 3rd booster shot and your fourth when it becomes available.

UK orders 35 million more Pfizer/BioNTech COVID vaccines

LONDON (Reuters) – Britain has agreed to buy 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of next year, as part of its preparations for booster shots and any new variants that could emerge. “While we continue to build this wall of defence from COVID-19, it’s also vital we do everything we can to protect the country for the future too – whether that’s from the virus as we know it or new variants,” health minister Sajid Javid said. Nick Note: I finally joined something.. The Illuminati did not want me. Even though my grand father was a high degree Maison and i learned the secret hand shake no one asked my to join. So now i am joining the 1 billion people injected with mind controlling nanbots……. And its was easy a few jabs in my arm… Nothing to study, no tests to take……. And i just found out Jessie Jackson also had his nanrobot jab to. I wish him a speedy recovery… I guess he should have gotten the second jab…..

 

Israel finds COVID-19 vaccine booster significantly lowers infection risk

JERUSALEM, Aug 22 (Reuters) – A third dose of Pfizer (PFE.N)‘s COVID-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, findings published by the Health Ministry showed on Sunday. The data were presented at a meeting of a ministry panel of vaccination experts on Thursday and uploaded to its website on Sunday, though the full details of the study were not released. The findings were on par with separate statistics reported last week by Israel’s Maccabi healthcare provider, one of several organisations administering booster shots to try to curb the Delta coronavirus variant. Breaking down statistics from Israel’s Gertner Institute and KI Institute, ministry officials said that among people aged 60 and over, the protection against infection provided from 10 days after a third dose was four times higher than after two doses.

A third jab for over 60-year-olds offered five to six times greater protection after 10 days with regard to serious illness and hospitalisation.

That age group is particularly vulnerable to COVID-19 and in Israel was the first to be inoculated when the vaccine drive began in late December. In recent weeks, the health ministry has said immunity has diminished over time for seniors and younger people as well. Most vaccinated people who fell severely ill in Israel were over 60 and with underlying health conditions. Israel started administering third jabs to over 60-year-olds on July 30. On Thursday it dropped the age of eligibility for a booster to 40, and included pregnant women, teachers and health care workers below that age. Third doses are given only to those who received their second shot at least five months ago.

The United States has announced plans to offer booster shots to all Americans, citing data showing diminishing protection. Canada, France and Germany have announced booster campaigns.

Fighting an outbreak of the Delta variant since June, Israel presently has one of the world’s highest infection rates per capita. Close to 1.5 million people out of the country’s 9.3 million population have taken a third jab. Nick Note: I had my 3rd booster shot two weeks ago. I am breathing easier.. get my Pun? I urge you to get your third vaccine you can play with the system. Its best not to delay. I am seeing a significant rise in people with the two vaccines testing positive, requiring hospitalization and the death rate is higher then before…. This is real world….. And yes i feel a certain release as the nanobots take control of my brain… Especially when the magnetism increases as i get near to 5G cell phone towers. I fell this urge to climb the towers closer to the antenna. that way i can be nearer to my  nanbit zombie master,,,,,,,  Yes Master,,,,…. i am here to bend my will to your will…….And be your cyber bitch…… Finally a cult i can embrace,(Crea Yoga did not work)  Its the nanobit defense… Its not my fault the nanobite made me do it!

Beating Back Delta Will Take Extra Covid Shot for Privileged Few

The roll out of a third dose of Covid vaccine has sparked debate on ethical and political grounds, since a large swath of the human population is yet to receive any inoculation. But the case for boosters on scientific grounds is building. The reason is delta. The most-infectious coronavirus variant to emerge so far is in a race with the human immune system, and there’s mounting evidence that delta is winning — at least initially. Fully vaccinated individuals infected with the variant have peak virus levels in the upper airways as high as those lacking immunity, a large study from the U.K. showed last week. That suggests people with delta-induced breakthrough infections also may be capable of transmitting the virus, frustrating efforts to curb the Covid pandemic. Waning antibody levels in some highly vaccinated populations such as Israel have prompted calls to offer boosters to blunt fresh waves of hospitalizations.  “The science is the boosters work, and they will definitely help,” said Shane Crotty, a virologist and professor at the La Jolla Institute for Immunology’s Center for Infectious Disease and Vaccine Research in California. In fully vaccinated, healthy adults, booster shots from Moderna Inc. as well as Pfizer Inc. and its partner BioNTech SE cause antibodies to rebound to peak levels, if not well beyond, Crotty said in a Zoom interview Friday. Those antibodies are also likely to be more durable and adept at fighting a wider range of SARS-CoV-2 strains, he said. That’s especially helpful in fighting delta. Researchers in China found the strain is detectable in patients four days after picking up the virus — two days earlier than was previously observed — indicating the strain makes individuals infectious sooner.  People infected with delta were also found to have significantly higher amounts of virus in their upper airways compared with infections caused by other strains. “It’s inherently tougher to stop with antibodies because there’s more of it and it’s a tougher challenge for the immune system,” Crotty said. Bolstering antibody levels with an extra dose of vaccine may enable the immune system to swiftly block delta on its arrival in the nose and throat, preventing the coronavirus from not only infecting cells and causing illness,  but also stopping it from spreading, he said. A slower antibody response, on the other hand, may increase infectiousness and worsen symptoms. “It’s a race between the virus and your immune system,” Crotty said. The faster the virus replicates, the less time antibodies have to block an infection. Still, even when a delayed antibody response does lead to infection, immunity generated by either vaccination or a natural infection is usually enough to prevent it causing severe illness in an otherwise healthy person, he said. Most pediatric vaccine regimens are administered over three shots, Crotty said. “A lot of that is about the mechanics of immune memory generation — that it’s frequently taken three exposures to get that,” he said. Three studies published by the U.S. Centers for Disease Control and Prevention last week showed that although delta may be hastening a decline in the effectiveness of the Moderna and Pfizer-BioNTech shots at preventing SARS-CoV-2 infections, including among nursing home residents, the vaccines remained a reliable shield against hospitalization over a six-month period. Delta can cause breakthrough infections and illness in people with lower antibody levels, said Andrew Pekosz, a professor of molecular microbiology at the Johns Hopkins University Bloomberg School of Public Health in Baltimore. “The good news is that vaccine efficacy against severe disease is still maintained,” he said. In addition, fully immunized people infected with delta may be infectious for a shorter period compared with individuals lacking immunity, reducing their propensity to transmit the virus, Pekosz said. It’s possible the infectiousness of vaccinated individuals could be further reduced with third shots using a different inoculation, delivery via a nasal spray, or using smaller amounts of the same vaccine, he said.  “We are still working out the mechanics of how best to use these vaccines for maximum protection,” said Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota in Minneapolis. “Our challenge is going to be how to continue to use these vaccines to maximize the most important aspect of public health: preventing infections.” Curbing spread is also key to preventing the emergence of variants even more dangerous than delta, he said. That goal must be sought globally with equity and solidarity, Osterholm said. “It’s a worldwide epidemic that will continue until you take care of it around the world,” he said. “From a humanitarian standpoint, this is obviously critical.” In the U.S., unvaccinated people are now swamping medical institutions in large swaths of the country, Johns Hopkins’ Pekosz said. “Vaccination would keep people out of the hospital, and that is the most important thing that vaccinations can do.” La Jolla’s Crotty estimates that more than 90% of SARS-CoV-2 transmission is from unvaccinated people. “In the U.S., we’ve got so many of those,” he said. “If you have two doses of vaccine, it’s way more valuable for those two doses to go to an unvaccinated person than people getting boosters if you want to talk about transmission,” Crotty said. “But if you can’t convince the people to get the damn things and somebody else wants them now, will it actually help the other person? Yeah, it will help them.”  Nick Note: Tell you what…BE a member of privileged society and get your 3rd booster shot. I have lived all over the world and we have always been privileged people.. better educated, freer, smarter and wealthier. Stop apologizing for GODS gifts and enjoy and appreciate them. One other thing. Americas are among the most hard working people in the world….. My opinion about third world shit holes is its hopeless… Poor people have poor ways…….. The poor will always be among you.